Literature DB >> 6686039

Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis.

M D Benson, F E Dwulet.   

Abstract

Serum prealbumin and retinol binding protein (RBP) concentrations were determined for 68 members of a kindred in Indiana with a familial type of systemic amyloidosis. Immunohistochemical studies on rectal and muscle biopsy material from individuals with this type of amyloidosis revealed staining of amyloid deposits with anti-prealbumin. Both the serum prealbumin and RBP concentrations were significantly depressed in 9 patients with amyloidosis when compared with normal controls and unaffected kin. In addition, the mean RBP serum concentration of 21 offspring of the patients with amyloidosis was significantly depressed. A more significant finding was that on the basis of the serum RBP concentrations, the offspring could be divided into 2 distinct groups. One group represented approximately 50% of the children and had serum prealbumin and RBP concentrations not significantly different from their afflicted parents. The second group had serum prealbumin and RBP concentrations not significantly different from those of normal controls and non-affected kin. These findings show that prealbumin and RBP serum concentrations are depressed in patients with the Indiana type of hereditary amyloidosis and that these serum abnormalities may be present long before development of clinical disease. They suggest that individuals with this genetic abnormality may be identified prior to clinical expression of the disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6686039     DOI: 10.1002/art.1780261211

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  A DNA test for Indiana/Swiss hereditary amyloidosis (FAP II).

Authors:  M R Wallace; P M Conneally; M D Benson
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

3.  A transthyretin variant (alanine 49) associated with familial amyloidotic polyneuropathy in a French family.

Authors:  M D Benson; J Julien; J Liepnieks; S Zeldenrust; M D Benson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

4.  Identification of carriers of a variant plasma prealbumin (transthyretin) associated with familial amyloidotic polyneuropathy type I.

Authors:  M D Benson; F E Dwulet
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

5.  Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).

Authors:  F E Dwulet; M D Benson
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

6.  A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family.

Authors:  M D Benson; J C Turpin; G Lucotte; S Zeldenrust; B LeChevalier; M D Benson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

7.  Senile systemic amyloidosis.

Authors:  P Pitkänen; P Westermark; G G Cornwell
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

8.  Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis.

Authors:  M R Wallace; F E Dwulet; E C Williams; P M Conneally; M D Benson
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

9.  Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.

Authors:  P D Gorevic; F C Prelli; J Wright; M Pras; B Frangione
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

10.  Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.

Authors:  Joel Buxbaum; James Koziol; Lawreen H Connors
Journal:  Amyloid       Date:  2008-12       Impact factor: 7.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.